ST-segment elevation myocardial infarction (STEMI)

Find all the latest content on STEMI published on this website.

Treating STEMI brings into play a series of clinical and organizational protocols in constant evolution. Today, patients presenting with STEMI are best treated by early reperfusion strategies of which primary PCI is the preferred method. Keep up-to-date on the role of adjunctive pharmacotherapy, advances in imaging techniques and the use of invasive imaging and functional assessment. Tools, devices and techniques as well as complications, such as the different types of vascular access or bleeding risk can be found here as well…

Filtered By
STEMI

516 results

STEMI - Tools, devices and techniques

15 Dec 2022 – From GulfPCR-GIM 2022

Among the 4 GulfPCR-GIM 2022 cases presented in this session, discover a curious case of type 4 dual left anterior descending artery presenting with STEMI, or an inferior wall STEMI with complete heart block in anomalous right coronary artery.

STEMI - Tools, devices and techniques

How should I treat STEMI?

14 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, watch a series of STEMI cases and learn more about left main stem, bifurcation, imaging, large thrombus situation, and cardiogenic shock in this particular context and follow the ensuing discussions to be better prepared if you were ever faced with it yourself.

How should I treat STEMI?

Distal vs conventional radial access for coronary angiography and/or intervention: a meta-analysis of randomized trials

30 Nov 2022

The present systematic review and meta-analysis by Ferrante et al aimed to provide a comprehensive quantitative analysis of the effects of DRA vs TRA, by pooling data from randomised controlled trials (RCT) comparing these two access sites when used for coronary angiography and/or percutaneous coronary intervention...

Reviewer

Aaysha Cader
Afonso Félix De Oliveira

Reviewer

Afonso Félix De Oliveira
Distal vs conventional radial access for coronary angiography and/or intervention: a meta-analysis of randomized trials

A leaking left main or a leaking stent shaft !?

23 Nov 2022

Contrast staining during coronary angioplasty is an ominous sign, usually indicating deep artery wedging by the guide catheter, or vessel dissection / perforation. The author presents an unusual cause of LMCA staining during primary LAD PCI.

Sreevatsa Nadig

Author

Sreevatsa Nadig
A leaking left main or a leaking stent shaft !?

Aspirin vs Clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study

08 Nov 2022

The HOST-EXAM trial1 was a prospective, randomised, open-label trial investigating clopidogrel monotherapy versus aspirin therapy in patients undergoing PCI with DES who had completed 6-18 months of DAPT with no ischaemic or bleeding complications. At 24 months follow-up, clopidogrel monotherapy significantly reduced the risk of the...

Nicola Ryan

Reviewer

Nicola Ryan
Aspirin vs Clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

AHA 2022: get the interventional cardiology perspective!

07 Nov 2022

Stay up to date with what is new and hot in interventional cardiology at #AHA22 in Chicago.

PCRonline @ AHA 2022

A patient with ACS – how should I treat the left main?

31 Oct 2022

Take a virtual trip to Chennai, India for this first PCR Webinar on the Road.

A patient with ACS – how should I treat the left main?

Optical coherence tomography fractional flow reserve and cardiovascular outcomes in patients with acute coronary syndrome

18 Oct 2022

Optical Coherence Tomography fractional flow reserve (OCT-FFR) has been shown to correlate well with wire-based FFR; however, clinical outcomes based on OCT-FFR are not well defined. In this retrospective study, the authors sought to investigate the relationship between OCT-FFR and long-term clinical outcomes in ACS. 

Nicola Ryan

Reviewer

Nicola Ryan
Optical coherence tomography fractional flow reserve and cardiovascular outcomes in patients with acute coronary syndrome